TY  - RPRT
TI  - United States FDA drug approvals are persistent and polycyclic: Insights into economic cycles, innovation dynamics, and national policy
AU  - Iraj Daizadeh
PY  - 2021
DO  - 10.1007/s43441-021-00279-8
UR  - https://arxiv.org/abs/2012.09627
ID  - 2012.09627
ER  -